Burkitt's lymphoma: a model for clinical oncology

Eur J Cancer. 1991;27(4):504-9. doi: 10.1016/0277-5379(91)90397-v.

Abstract

Burkitt's lymphoma, a pathological entity initially described in Africa, is the most common childhood lymphoma in western countries and represents approximately 5% of all adults lymphomas. This high grade small non-cleaved diffuse lymphoma is a model with which to study the relations between cancer and viruses, the chromosomes and the genes. Burkitt's lymphoma is also a model for clinical research which allows evaluation of the dose effect concept with chemotherapy and the role of megatherapy with autologous bone marrow rescue.

Publication types

  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Burkitt Lymphoma / drug therapy*
  • Burkitt Lymphoma / epidemiology
  • Burkitt Lymphoma / genetics
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Male